Public procurement notice: Contract Notice
Published: 2016-07-02
Buyer: Barts Health NHS Trust
Country: UK
Region: LONDON
Contract type: Supplies
Procedure: Restricted procedure
CPV classification: 33600000: Pharmaceutical products | 73111000 | 79991000
Estimated value: 600000 GBP
Submission deadline: 2016-07-29
Award criteria: The most economic tender

Technical requirements: Barts Health NHS Trust (‘the Trust’) is seeking to appoint a partner to manufacture, package and supply Adenosine 130mg/130mL pre-filled bags to the Trust's specification requirements.
The supplies will be for the Trust's use in its hospitals and also for the Trust's onward commercial supply to third party customers. Therefore the partner will need to work with the Trust to plan capacity in order to produce and maintain stock to fulfil demand growth for Adenosine through the Trust's distribution and sales channels.
The initial production of supplies will be under a MHRA (Medicines Health Regulatory Authority) Manufactures Specials License held by the Trust (through Barts Health Pharmaceuticals) but the appointed partner will also need to be able to support the Trust in the manufacture, packaging and supply of the products if the Trust progresses the product under an MIA license.
The appointed provider may also be called upon to provide pharmaceutical research testing services as to the stability testing of the product in order to generate data sets for the Trust's licensing applications.
The manufacture and supply contract will be for an initial term of 2 years with an option to extend (exercisable by the Trust during the initial term) for a further 1 year.
The appointed partner will need to have capacity to be able to manufacture and deliver an initial minimum batch of 18 000 units by 28.11.2016.
The estimated supplies demand for the Trust's own use is estimated to be in the region of 40 000 of units per annum and therefore approximately,120 000 over the maximum 3 year contract length. However, actual demand may fluctuate depending on the Trust's ongoing clinical needs.
The estimated supplies demand for use to supply the Trust's third party customers is difficult to predict and dependent on many commercial factors. However, the estimated range factoring a degree of projected growth would be in the region of 120 000 to 180 000 units over the maximum 3 year term.
The estimated value range below is on the basis of combining the estimated demand for these 2 purposes.
Bidders should seek independent legal and commercial advice in relation to the potential value of the opportunity of the scheme as a whole.
The contract between the Trust and the supplier will be for an initial term of 2 years with an option to extend (exercisable by the Trust during the initial term) for a further 1 year.
The Trust reserves the right to require deposits, guarantees, bonds or other forms of appropriate security.
Expressions of interest in response to this contract notice may be submitted by a single bidder or a consortium. The contracting authority reserves the right to require groupings of contractors to take a particular legal form or to require a single contractor to take primary liability or to require that each party undertakes joint and several liability.
In accordance with Articles 57 to 63 of Directive 2014/24/EU of the European Parliament and of the Council and Regulations 57 to 63 of the Public Contracts Regulations 2015 and as set out in the pre-qualification questionnaire available from the address in Section I.1)
In accordance with Article 58 to 63 of Directive 2014/24/EU of the European Parliament and of the Council and Regulation 58 to 63 of the Public Contracts Regulations 2015 and as set out in the pre-qualification questionnaire which is available from the address in Section I.1)

Eligibility requirements: In accordance with Articles 57 to 63 of Directive 2014/24/EU of the European Parliament and of the Council and Regulations 57 to 63 of the Public Contracts Regulations 2015 and as set out in the pre-qualification questionnaire available from the address in Section I.1) In accordance with Article 58 to 63 of Directive 2014/24/EU of the European Parliament and of the Council and Regulation 58 to 63 of the Public Contracts Regulations 2015 and as set out in the pre-qualification questionnaire which is available from the address in Section I.1) As set out in the pre-qualification questionnaire. In accordance with Articles 58 to 63 of Directive 2014/24/EU of the European Parliament and of the Council and Regulation 58 to 63 of the Public Contracts Regulations 2015 and as set out in the pre-qualification questionnaire which is available from the address in Section I.1) As set out in the pre-qualification questionnaire.
In accordance with Article 58 to 63 of Directive 2014/24/EU of the European Parliament and of the Council and Regulation 58 to 63 of the Public Contracts Regulations 2015 and as set out in the pre-qualification questionnaire which is available from the address in Section I.1) As set out in the pre-qualification questionnaire.
In accordance with Article 58 to 63 of Directive 2014/24/EU of the European Parliament and of the Council and Regulation 58 to 63 of the Public Contracts Regulations 2015 and as set out in the pre-qualification questionnaire which is available from the address in Section I.1)
As set out in the pre-qualification questionnaire.
In accordance with Articles 58 to 63 of Directive 2014/24/EU of the European Parliament and of the Council and Regulation 58 to 63 of the Public Contracts Regulations 2015 and as set out in the pre-qualification questionnaire which is available from the address in Section I.1) As set out in the pre-qualification questionnaire.
In accordance with Articles 58 to 63 of Directive 2014/24/EU of the European Parliament and of the Council and Regulation 58 to 63 of the Public Contracts Regulations 2015 and as set out in the pre-qualification questionnaire which is available from the address in Section I.1)